The Western Journal on MSN3d
Biden and Harris Raided Medicare to Fund Green New Deal: Premiums Are Now Set to Spike
When Democrats rammed through the Inflation Reduction Act during the days they controlled all of Washington, D.C., it ignited ...
STAT5d
Pharmalittle: We’re reading about a Merck deal, GSK cancer drug data, and more
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova
Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...
Crain's New York5d
Midtown-based drug company inks $150M deal with Novartis
Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...
Merck Snags Chinese Cancer Drug For Up to $3.3 Billion
Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...
BioPharma Dive5d
Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy
The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...
Spirovant Sciences achieves milestone for experimental cystic fibrosis treatment
The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...
BioNTech strikes $950mn deal for Chinese drugmaker Biotheus
BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...